Cargando…

1724. Varicella Infections and Vaccination Rates Among Pediatric Solid Organ Transplant Recipients: A Single-Center, Multi-Organ Retrospective Experience (2011-2021)

BACKGROUND: The two-dose varicella-zoster virus (VZV) immunization schedule significantly decreased VZV infections in the US. Yet, among pediatric solid organ transplant recipients (SOT), the characterization of pre-transplant VZV immunity, VZV exposure with progression to disease, and disease outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinoza-Candelaria, Gabriela, Green, Michael D, Martin, Judith M, Sojati, Jorna, Michaels, Marian G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676906/
http://dx.doi.org/10.1093/ofid/ofad500.1556
_version_ 1785150004466286592
author Espinoza-Candelaria, Gabriela
Green, Michael D
Martin, Judith M
Sojati, Jorna
Michaels, Marian G
author_facet Espinoza-Candelaria, Gabriela
Green, Michael D
Martin, Judith M
Sojati, Jorna
Michaels, Marian G
author_sort Espinoza-Candelaria, Gabriela
collection PubMed
description BACKGROUND: The two-dose varicella-zoster virus (VZV) immunization schedule significantly decreased VZV infections in the US. Yet, among pediatric solid organ transplant recipients (SOT), the characterization of pre-transplant VZV immunity, VZV exposure with progression to disease, and disease outcomes remain poorly described. METHODS: We performed a retrospective analysis of patients < 18 years old who received a SOT between Jan 1, 2011 - Dec 31, 2021, at the UPMC Children's Hospital of Pittsburgh, a quaternary, multi-organ pediatric care center. Inpatient, outpatient, and telephone encounters were reviewed as documented in the patients’ electronic health records (EHRs) via automated and manual data extraction. RESULTS: 674 patients underwent 832 SOT procedures; 370 children met the inclusion criteria. 287 patients had documentation of their VZV pre-transplant vaccine status and no contraindication for vaccination; 59% had unknown, negative, or indeterminate pre-transplant VZV IgG. While 257 children received at least 1 VZV dose before SOT, another dose was administered for only 41% of those with negative or indeterminate serology in the pre-transplant period. 35 children did not have a documented VZV pre-transplant immunization status; 63% had unknown or negative VZV IgG and were eligible for vaccination by age and immunocompetence. 33 patients had VZV exposures; 2 children developed VZV disease - neither had received post-exposure prophylaxis (PEP). 5 patients were prescribed an antiviral as PEP, 2 received IVIG incidentally, and none received VZV immunoglobulin. In total, there were 4 primary VZV and 4 herpes zoster (HZ) medically attended cases among 8 patients. All 8 received antiviral treatment; 3 in the inpatient setting and 5 exclusively outpatient. All cases were limited to cutaneous lesions without dissemination. None of the patients who developed primary VZV had conclusive evidence of protective VZV IgG pre-transplant. Post-herpetic neuralgia complicated 1 HZ case. CONCLUSION: VZV exposure and disease still occur, albeit at low levels and with mild manifestations, among pediatric SOT recipients in the two-dose VZV vaccine era. Optimization of VZV immunity in the pre-transplant period and preventing progression to disease after exposure to VZV remain goals of care. DISCLOSURES: Michael D. Green, MD, MPH, ADMA: Advisor/Consultant|Allovir: Advisor/Consultant|Bristol Myers Squibb: Advisor/Consultant|ITB-MED: Advisor/Consultant Judith M. Martin, MD, Merck, Sharp and Dhome: Grant/Research Support Marian G. Michaels, MD, MPH, Merck: Grant/Research Support|Viracor: Grant/Research Support
format Online
Article
Text
id pubmed-10676906
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106769062023-11-27 1724. Varicella Infections and Vaccination Rates Among Pediatric Solid Organ Transplant Recipients: A Single-Center, Multi-Organ Retrospective Experience (2011-2021) Espinoza-Candelaria, Gabriela Green, Michael D Martin, Judith M Sojati, Jorna Michaels, Marian G Open Forum Infect Dis Abstract BACKGROUND: The two-dose varicella-zoster virus (VZV) immunization schedule significantly decreased VZV infections in the US. Yet, among pediatric solid organ transplant recipients (SOT), the characterization of pre-transplant VZV immunity, VZV exposure with progression to disease, and disease outcomes remain poorly described. METHODS: We performed a retrospective analysis of patients < 18 years old who received a SOT between Jan 1, 2011 - Dec 31, 2021, at the UPMC Children's Hospital of Pittsburgh, a quaternary, multi-organ pediatric care center. Inpatient, outpatient, and telephone encounters were reviewed as documented in the patients’ electronic health records (EHRs) via automated and manual data extraction. RESULTS: 674 patients underwent 832 SOT procedures; 370 children met the inclusion criteria. 287 patients had documentation of their VZV pre-transplant vaccine status and no contraindication for vaccination; 59% had unknown, negative, or indeterminate pre-transplant VZV IgG. While 257 children received at least 1 VZV dose before SOT, another dose was administered for only 41% of those with negative or indeterminate serology in the pre-transplant period. 35 children did not have a documented VZV pre-transplant immunization status; 63% had unknown or negative VZV IgG and were eligible for vaccination by age and immunocompetence. 33 patients had VZV exposures; 2 children developed VZV disease - neither had received post-exposure prophylaxis (PEP). 5 patients were prescribed an antiviral as PEP, 2 received IVIG incidentally, and none received VZV immunoglobulin. In total, there were 4 primary VZV and 4 herpes zoster (HZ) medically attended cases among 8 patients. All 8 received antiviral treatment; 3 in the inpatient setting and 5 exclusively outpatient. All cases were limited to cutaneous lesions without dissemination. None of the patients who developed primary VZV had conclusive evidence of protective VZV IgG pre-transplant. Post-herpetic neuralgia complicated 1 HZ case. CONCLUSION: VZV exposure and disease still occur, albeit at low levels and with mild manifestations, among pediatric SOT recipients in the two-dose VZV vaccine era. Optimization of VZV immunity in the pre-transplant period and preventing progression to disease after exposure to VZV remain goals of care. DISCLOSURES: Michael D. Green, MD, MPH, ADMA: Advisor/Consultant|Allovir: Advisor/Consultant|Bristol Myers Squibb: Advisor/Consultant|ITB-MED: Advisor/Consultant Judith M. Martin, MD, Merck, Sharp and Dhome: Grant/Research Support Marian G. Michaels, MD, MPH, Merck: Grant/Research Support|Viracor: Grant/Research Support Oxford University Press 2023-11-27 /pmc/articles/PMC10676906/ http://dx.doi.org/10.1093/ofid/ofad500.1556 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Espinoza-Candelaria, Gabriela
Green, Michael D
Martin, Judith M
Sojati, Jorna
Michaels, Marian G
1724. Varicella Infections and Vaccination Rates Among Pediatric Solid Organ Transplant Recipients: A Single-Center, Multi-Organ Retrospective Experience (2011-2021)
title 1724. Varicella Infections and Vaccination Rates Among Pediatric Solid Organ Transplant Recipients: A Single-Center, Multi-Organ Retrospective Experience (2011-2021)
title_full 1724. Varicella Infections and Vaccination Rates Among Pediatric Solid Organ Transplant Recipients: A Single-Center, Multi-Organ Retrospective Experience (2011-2021)
title_fullStr 1724. Varicella Infections and Vaccination Rates Among Pediatric Solid Organ Transplant Recipients: A Single-Center, Multi-Organ Retrospective Experience (2011-2021)
title_full_unstemmed 1724. Varicella Infections and Vaccination Rates Among Pediatric Solid Organ Transplant Recipients: A Single-Center, Multi-Organ Retrospective Experience (2011-2021)
title_short 1724. Varicella Infections and Vaccination Rates Among Pediatric Solid Organ Transplant Recipients: A Single-Center, Multi-Organ Retrospective Experience (2011-2021)
title_sort 1724. varicella infections and vaccination rates among pediatric solid organ transplant recipients: a single-center, multi-organ retrospective experience (2011-2021)
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10676906/
http://dx.doi.org/10.1093/ofid/ofad500.1556
work_keys_str_mv AT espinozacandelariagabriela 1724varicellainfectionsandvaccinationratesamongpediatricsolidorgantransplantrecipientsasinglecentermultiorganretrospectiveexperience20112021
AT greenmichaeld 1724varicellainfectionsandvaccinationratesamongpediatricsolidorgantransplantrecipientsasinglecentermultiorganretrospectiveexperience20112021
AT martinjudithm 1724varicellainfectionsandvaccinationratesamongpediatricsolidorgantransplantrecipientsasinglecentermultiorganretrospectiveexperience20112021
AT sojatijorna 1724varicellainfectionsandvaccinationratesamongpediatricsolidorgantransplantrecipientsasinglecentermultiorganretrospectiveexperience20112021
AT michaelsmariang 1724varicellainfectionsandvaccinationratesamongpediatricsolidorgantransplantrecipientsasinglecentermultiorganretrospectiveexperience20112021